Answer
Breastfeeding should be discontinued during treatment with Zydelig (idelalisib), as it is unknown whether idelalisib or its metabolites enter human milk and a risk to newborns or infants cannot be excluded.
Sources for this answer
- Zydelig 150mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 23Document updated
Sources checked